Rare diseases
Investigational molecules
Locations
Back to Germany7 clinical trials in Beelitz, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A study to evaluate the safety and effectiveness of NIO752 in patients with progressive supranuclear palsy
GermanyA study comparing prasinezumab with placebo for people with early-stage Parkinson's disease
GermanyA Study of Emrusolmin Safety and Effectiveness in Adults with Multiple System Atrophy, a Brain and Nerve Disorder
GermanyStudy of Amlenetug for Patients with Multiple System Atrophy
GermanyStudy of FNP-223 tablets to slow disease progression in patients with Progressive Supranuclear Palsy (PSP)
GermanyStudy of Emrusolmin for Treating Adults with Multiple System Atrophy
GermanyStudy on BIA 28-6156 for Parkinson's Disease in Patients with GBA1 Gene Variant
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on Multiple System Atrophy (MSA), evaluating new therapeutic compounds aimed at slowing disease progression and improving patient outcomes.
Multiple investigational treatments are being assessed through controlled clinical studies.
Research initiatives targeting Progressive Supranuclear Palsy (PSP), with studies designed to evaluate innovative therapeutic approaches for this rare neurological condition.
Comprehensive 52-week studies are underway to assess new treatment options.
Specialized research focusing on GBA1 gene-related Parkinson's Disease, investigating targeted treatments to address motor function and disease progression.
Advanced clinical trials utilizing standardized rating scales to measure treatment effectiveness.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
